Literature DB >> 22320183

Pericellular pH homeostasis is a primary function of the Warburg effect: inversion of metabolic systems to control lactate steady state in tumor cells.

Elizabeth A Mazzio1, Nawal Boukli, Nery Rivera, Karam F A Soliman.   

Abstract

The Warburg effect describes a heightened propensity of tumor cells to produce lactic acid in the presence or absence of O(2) . A generally held notion is that the Warburg effect is related to energy. Using whole-genome, proteomic MALDI-TOF-MS and metabolite analysis, we investigated the Warburg effect in malignant neuroblastoma N2a cells. The findings show that the Warburg effect serves a functional role in regulating acidic pericellular pH (pHe), which is mediated by metabolic inversion or a fluctuating dominance between glycolytic-rate substrate level phosphorylation (SLP) and mitochondrial (mt) oxidative phosphorylation (OXPHOS) to control lactic acid production. The results also show that an alkaline pHe caused an elevation in SLP/OXPHOS ratio (approximately 98% SLP/OXPHOS); while the ratio was approximately 56% at neutral pHe and approximately 93% in acidic pHe. Acidic pHe paralleled greater expression of mitochondrial biogenesis and OXPHOS genes, such as complex III-V (Uqcr10, Atp5 and Cox7c), mt Fmc1, Romo1, Tmem 173, Tomm6, aldehyde dehydrogenase, mt Sod2 mt biogenesis component PPAR-γ co-activator 1 adjunct to loss of mt fission (Mff). Moreover, acidic pHe corresponded to metabolic efficiency evidenced by a rise in mTOR nutrient sensor GβL, its downstream target (Eif4ebp1), insulin modulators (Trib3 and Fetub) and loss of catabolic (Hadhb, Bdh1 and Pygl)/glycolytic processes (aldolase C, pyruvate kinase, Nampt and aldose-reductase). In contrast, alkaline pHe initiated loss of mitofusin 2, complex II-IV (Sdhaf1, Uqcrq, Cox4i2 and Aldh1l2), aconitase, mitochondrial carrier triple repeat 1 and mt biosynthetic (Coq2, Coq5 and Coq9). In conclusion, the Warburg effect might serve as a negative feedback loop that regulates the pHe toward a broad acidic range by altering lactic acid production through inversion of metabolic systems. These effects were independent of changes in O(2) concentration or glucose supply.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22320183      PMCID: PMC3294166          DOI: 10.1111/j.1349-7006.2012.02206.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  55 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

Authors:  Kathrin Zaugg; Yi Yao; Patrick T Reilly; Karuppiah Kannan; Reza Kiarash; Jacqueline Mason; Ping Huang; Suzanne K Sawyer; Benjamin Fuerth; Brandon Faubert; Tuula Kalliomäki; Andrew Elia; Xunyi Luo; Vincent Nadeem; David Bungard; Sireesha Yalavarthi; Joseph D Growney; Andrew Wakeham; Yasmin Moolani; Jennifer Silvester; Annick You Ten; Walbert Bakker; Katsuya Tsuchihara; Shelley L Berger; Richard P Hill; Russell G Jones; Ming Tsao; Murray O Robinson; Craig B Thompson; Guohua Pan; Tak W Mak
Journal:  Genes Dev       Date:  2011-05-15       Impact factor: 11.361

3.  Clinical applications of positron emission tomography in hepatic tumors.

Authors:  Susumu Shiomi; Joji Kawabe
Journal:  Hepatol Res       Date:  2011-07       Impact factor: 4.288

4.  Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Zhao Lin; Adam Ertel; Neal Flomenberg; Agnieszka K Witkiewicz; Ruth C Birbe; Anthony Howell; Stephanos Pavlides; Ricardo Gandara; Richard G Pestell; Federica Sotgia; Nancy J Philp; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

5.  The anti-apoptotic protein HAX-1 is a regulator of cardiac function.

Authors:  Wen Zhao; Jason R Waggoner; Zhi-Guo Zhang; Chi Keung Lam; Peidong Han; Jiang Qian; Paul M Schroder; Bryan Mitton; Aikaterini Kontrogianni-Konstantopoulos; Seth L Robia; Evangelia G Kranias
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

6.  Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors.

Authors:  Linda E B Stuhr; Vegard V Iversen; Oddbjørn Straume; Bjørn O Maehle; Rolf K Reed
Journal:  Cancer Lett       Date:  2004-07-08       Impact factor: 8.679

7.  Molecular crowding defines a common origin for the Warburg effect in proliferating cells and the lactate threshold in muscle physiology.

Authors:  Alexei Vazquez; Zoltán N Oltvai
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.

Authors:  Andreja Šmerc; Eva Sodja; Matic Legiša
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

9.  The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.

Authors:  Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Rob C M Pelger; Gabri van der Pluijm
Journal:  Clin Exp Metastasis       Date:  2011-06-07       Impact factor: 5.150

10.  From genomics to chemical genomics: new developments in KEGG.

Authors:  Minoru Kanehisa; Susumu Goto; Masahiro Hattori; Kiyoko F Aoki-Kinoshita; Masumi Itoh; Shuichi Kawashima; Toshiaki Katayama; Michihiro Araki; Mika Hirakawa
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  24 in total

1.  Metabolic reprogramming as a continuous changing behavior of tumor cells.

Authors:  Silvia Peppicelli; Francesca Bianchini; Lido Calorini
Journal:  Tumour Biol       Date:  2015-07-10

2.  Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.

Authors:  Nerissa Therese Viola-Villegas; Sean D Carlin; Ellen Ackerstaff; Kuntal K Sevak; Vadim Divilov; Inna Serganova; Natalia Kruchevsky; Michael Anderson; Ronald G Blasberg; Oleg A Andreev; Donald M Engelman; Jason A Koutcher; Yana K Reshetnyak; Jason S Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-01       Impact factor: 11.205

3.  Modeling of Tumor Growth with Input from Patient-Specific Metabolomic Data.

Authors:  Hunter A Miller; John Lowengrub; Hermann B Frieboes
Journal:  Ann Biomed Eng       Date:  2022-01-26       Impact factor: 3.934

Review 4.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

5.  Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation.

Authors:  Silvia Peppicelli; Alessandra Toti; Elisa Giannoni; Francesca Bianchini; Francesca Margheri; Mario Del Rosso; Lido Calorini
Journal:  Cell Cycle       Date:  2016-06-06       Impact factor: 4.534

Review 6.  Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Authors:  Surendra Singh; Chad Brocker; Vindhya Koppaka; Ying Chen; Brian C Jackson; Akiko Matsumoto; David C Thompson; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-11-27       Impact factor: 7.376

7.  Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data.

Authors:  Hunter A Miller; Xinmin Yin; Susan A Smith; Xiaoling Hu; Xiang Zhang; Jun Yan; Donald M Miller; Victor H van Berkel; Hermann B Frieboes
Journal:  Lung Cancer       Date:  2021-04-15       Impact factor: 6.081

8.  Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach.

Authors:  Silvia Peppicelli; Francesca Bianchini; Lido Calorini
Journal:  Oncoscience       Date:  2015-02-09

9.  The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

Authors:  Elisabetta Rovida; Silvia Peppicelli; Silvia Bono; Francesca Bianchini; Ignazia Tusa; Giulia Cheloni; Ilaria Marzi; Maria Grazia Cipolleschi; Lido Calorini; Persio Dello Sbarba
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells.

Authors:  Shihab Deiab; Elizabeth Mazzio; Suresh Eyunni; Oshlii McTier; Nelly Mateeva; Faisel Elshami; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.